Epm2a acts as a protective factor in prostate cancer, evidence from a real-world patient cohort

HIGHLIGHTS

SUMMARY

    Of laforin remain unclear, its functions in glycogen regulation, protecting cells from ER stress conditions, suppressing cytotoxicity production, autophagy regulation and tumor suppression have been proposed (Worby et_al, 2006; Garyali et_al, 2009; Vernia et_al, 2009; Gentry et_al, 2013). This evidence suggests that EPM2A gene_expression has diagnostic potential in early tumor detection, can reflect the progression trend and may become a novel therapeutic target. To define high-risk PCA, prostate-specific antigen (PSA), T, N, M classification and Gleason scores (GS) have been used to construct risk stratification schemes (Kattan et_al, 1998; D`Amico et_al . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?